Loading
Insider Decl.
689
Thresholds
n/a
Buy Volume
€234,420
7 ops. · all time
Sell Volume
€254M
272 ops. · all time
Who traded when
BuySaleAdrian Wong10 sales
David Harquail9 sales
Sandip Rana8 sales
Boris de Vries7 sales
Bonavie Tek6 sales
Christian Thatcher4 sales
+9 other insiders
Analyst consensus: bullish or bearish?
Analysts rate Franco-Nevada Corporation Buy (bullish), based on 9 analysts. Average price target: CA$399.78.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,943 of 26,286 companies
59.5
score / 100
Value28
Quality91
FCF yld-1.1%
Earn yld1.8%
EV/EBITDA35.9x
ROE20%
Gross mgn74%
Net mgn61%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$340.75
Analyst consensus
9 analystsBuy
CA$268.43Target CA$399.78(+17%)CA$477.58
Income statement
RevenueCA$1.8B
Gross profitCA$1.3B74% margin
EBITDACA$1.7B95% margin
Net incomeCA$1.1B64.2% margin
Valuation
PER (trailing)32.2x
PER (forward)37.7x
P/Book5.6x
Beta0.94
Balance sheet & cash
Market capCA$65.7B
Free Cash Flow-CA$703M
Profitability & ownership
ROE19.9%
ROA13.7%
% insiders0.6%
% institutions84.9%
Last declaration on 24 August 2026
Declarations689 total
5,000 shares@ CA$364.36510.0026% mcap28.5% of flowCommon SharesTSXSEDI:4767831
5,000 shares@ CA$75.455.9% of flowOptionsTSXSEDI:4767827
10,000 shares@ CA$344.87270.0049% mcap53.8% of flowCommon SharesTSXSEDI:4766636
10,000 shares@ CA$75.4511.8% of flowOptionsTSXSEDI:4766634
1,826 shares@ CA$284.59332.7% of flowCommon SharesTSXSEDI:4620388
1,826 shares@ CA$65.760.6% of flowCommon SharesTSXSEDI:4620386
268 shares@ CA$65.761.3% of flowCommon SharesTSXSEDI:4619690
2,000 shares@ CA$280.13342.9% of flowCommon SharesTSXSEDI:4619698
2,000 shares@ CA$65.760.7% of flowCommon SharesTSXSEDI:4619696
54 sharesCommon SharesTSXSEDI:4614784
95 sharesCommon SharesTSXSEDI:4614783
115 shares@ CA$290.52225.3% of flowCommon SharesTSXSEDI:4611497
115 shares@ CA$168.433.1% of flowCommon SharesTSXSEDI:4611496
Common SharesTSXSEDI:4608989
1,560 shares@ CA$196.9296.2% of flowCommon SharesTSXSEDI:4609022
62 shares@ CA$197.093.8% of flowCommon SharesTSXSEDI:4609021
62 sharesCommon SharesTSXSEDI:4609018
5,446 sharesCommon SharesTSXSEDI:4609016
6,000 sharesCommon SharesTSXSEDI:4609005
4,000 sharesCommon SharesTSXSEDI:4608999
Common SharesTSXSEDI:4606886
15,050 sharesCommon SharesTSXSEDI:4606890
15,050 sharesCommon SharesTSXSEDI:4606888
155 shares@ CA$309.003.6% of flowCommon SharesTSXSEDI:4582252
200 shares@ CA$309.554.7% of flowCommon SharesTSXSEDI:4582253
25 of 689 declarations
About Franco-Nevada Corporation
At Franco-Nevada Corporation, the 265 sales (263 with an amount) total EUR 244 million, with a median of EUR 319,416, against 6 purchases worth EUR 212,340. Two Directors of Issuer top the list: David Harquail, EUR 13,073,701 on May 11, 2020, and Pierre Lassonde, EUR 10,420,509 on March 27, 2017 then EUR 9,075,378 on September 4, 2019. Pierre Lassonde also files the most, 75 times, 57 of them sales.
Purchases weigh only 2% of market trades and are small: Adrian Wong, Senior Officer of Issuer, EUR 83,680 on September 27, 2021, then Jacques Perron, Director of Issuer, EUR 34,728 on June 22, 2023 and EUR 33,988 on May 7, 2024. The median purchase is EUR 33,746.
Read moreShow less
Of 652 filings, 276 are option exercises and 37 are grants. The year 2025 is the busiest, with 135 filings, against 16 in 2022. The median publication delay is 2 days. Over the last twelve months: 23 filings, 9 sales and no purchase. This Canadian company in the Chemicals sector is worth CAD 65.7 billion.
